Skip to main content
. 2023 Aug 17;21:271. doi: 10.1186/s12951-023-02058-z

Fig. 4.

Fig. 4

The diagram shows the preparation of SHPEMs and the targeting of SHPEMs across ECs to CD44 receptors on macrophages within the plaque, followed by nanoparticle disintegration for anti-inflammatory and ROS depletion purposes. Copyright 2020 by Mu [104]